AVLSA
Atlas Venture Life Science Advisors’s Spero Therapeutics SPRO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-305,255
| Closed | -$220K | – | 13 |
|
|
2025
Q1 | $220K | Hold |
305,255
| – | – | 0.04% | 13 |
|
|
2024
Q4 | $314K | Sell |
305,255
-97,630
| -24% | -$101K | 0.04% | 13 |
|
|
2024
Q3 | $540K | Sell |
402,885
-132,451
| -25% | -$177K | 0.05% | 14 |
|
|
2024
Q2 | $696K | Sell |
535,336
-72,277
| -12% | -$94K | 0.07% | 15 |
|
|
2024
Q1 | $1.05M | Sell |
607,613
-405,825
| -40% | -$698K | 0.1% | 16 |
|
|
2023
Q4 | $1.49M | Hold |
1,013,438
| – | – | 0.18% | 16 |
|
|
2023
Q3 | $1.23M | Hold |
1,013,438
| – | – | 0.19% | 15 |
|
|
2023
Q2 | $1.47M | Sell |
1,013,438
-17,722
| -2% | -$25.7K | 0.18% | 15 |
|
|
2023
Q1 | $1.5M | Hold |
1,031,160
| – | – | 0.2% | 16 |
|
|
2022
Q4 | $1.78M | Hold |
1,031,160
| – | – | 0.21% | 16 |
|
|
2022
Q3 | $2.06M | Hold |
1,031,160
| – | – | 0.23% | 16 |
|
|
2022
Q2 | $764K | Hold |
1,031,160
| – | – | 0.13% | 16 |
|
|
2022
Q1 | $8.97M | Hold |
1,031,160
| – | – | 1.13% | 12 |
|
|
2021
Q4 | $16.5M | Buy |
+1,031,160
| New | +$16.5M | 1.52% | 11 |
|